CAS: 1803171-55-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ravulizumab REF: TM-T76867CAS: 1803171-55-2 | > 95% | 235.00 €~2,547.00 € | Tue 04 Mar 25 |
 | Ravulizumab REF: 3D-CLA1459CAS: 1803171-55-2 | - - - | To inquire | Fri 14 Mar 25 |
Ravulizumab
CAS:1803171-55-2
Ravulizumab (ALXN1210) is a humanized antibody for blocking complement activation, treating PNH, aHUS, and myasthenia …
Purity:
> 95%
Color and Shape:
Liquid
Molecular weight:
145.80 kDa
Ref: TM-T76867
| 1mg | 235.00 € | ||
| 5mg | 588.00 € | ||
| 10mg | 944.00 € | ||
| 25mg | 1,396.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,547.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
Ravulizumab
CAS:1803171-55-2
Anti-Complement component 5 humanized monoclonal antibody; paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome treatment
Ref: 3D-CLA1459
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 14 Mar 2025
